Emily Field
Emily Field is a prominent analyst in the pharmaceutical sector, currently leading European pharmaceutical research at Barclays. She has recently gained attention for her insights into the potential impacts of trade tariffs on prescription drug prices, as well as her interactions with clients concerned about the implications of U.S. trade policies under President Trump's administration.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Belarus | 1 | 5.00 | 0.06% | +0% | 9,449,323 | 5,833 | $60,000 | 37$ |
| Totals | 1 | 9,449,323 | 5,833 | $60,000 | 37$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Belarus:
Analyst Emily Field from Barclays describes the market share decline of Novo Nordisk as a 'slow-motion car crash'.
5
Hungary:
Emily Field, an analyst at Barclays, commented on the situation regarding the medications.
5
Slovenia:
Emily Field is the head of European pharmaceutical equity research at Barclays who expressed concerns about tariffs on prescription drugs.
5